These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2733415)

  • 1. Treatment of toxic shock syndrome with endotoxin-neutralizing antibody.
    Priest BP; Schlievert PM; Dunn DL
    J Surg Res; 1989 Jun; 46(6):527-31. PubMed ID: 2733415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Bogard WC; Cerra FB
    Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.
    Blanco L; Choi EM; Connolly K; Thompson MR; Bonventre PF
    Infect Immun; 1990 Sep; 58(9):3020-8. PubMed ID: 1696937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
    Rubin RM; Noland J; Rosenbaum JT
    Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoprotective monoclonal antibody to lipopolysaccharide.
    Kirkland TN; Ziegler EJ
    J Immunol; 1984 May; 132(5):2590-2. PubMed ID: 6201551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide-Induced Toxic Shock Syndrome in Rabbits.
    Stach CS; Schlievert PM
    Methods Mol Biol; 2016; 1396():67-71. PubMed ID: 26676037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody.
    Dunn DL; Bogard WC; Cerra FB
    Arch Surg; 1985 Jan; 120(1):50-3. PubMed ID: 3917664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with an anti-idiotypic antibody against the broadly lipopolysaccharide-reactive antibody WN1 222-5 induces Escherichia coli R3-core-type specific antibodies in rabbits.
    Brade L; Heine H; Raina S; Klein G; Di Padova F; Brade H; Müller-Loennies S
    Innate Immun; 2012 Apr; 18(2):279-93. PubMed ID: 21844130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-lipopolysaccharide monoclonal antibodies inhibit macrophage TNF messenger RNA synthesis in vitro.
    Battafarano RJ; Burd RS; Cody CS; Kellogg TA; Raymond CS; Ratz CA; Dunn DL
    J Surg Res; 1993 Apr; 54(4):342-8. PubMed ID: 8331928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.
    Dinges MM; Schlievert PM
    Infect Immun; 2001 Mar; 69(3):1256-64. PubMed ID: 11179286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide.
    Hoffman WD; Pollack M; Banks SM; Koev LA; Solomon MA; Danner RL; Koles N; Guelde G; Yatsiv I; Mouginis T
    J Infect Dis; 1994 Mar; 169(3):553-61. PubMed ID: 7512609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
    Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
    Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection.
    Dunn DL; Ewald DC; Chandan N; Cerra FB
    Arch Surg; 1986 Jan; 121(1):58-62. PubMed ID: 3942500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model.
    Dunn DL
    Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
    Feng MH; Cui JC; Nakane A; Hu DL
    Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigen and endotoxin synergize in the induction of lethal shock.
    Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
    Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies.
    Su SD; Ward MM; Apicella MA; Ward RE
    J Immunol; 1990 Nov; 145(9):2994-3001. PubMed ID: 2212671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of endotoxin contamination in the evaluation of antibodies to lipopolysaccharides in a murine model of gram-negative sepsis.
    Chong KT; Huston M
    J Infect Dis; 1987 Nov; 156(5):713-9. PubMed ID: 3309071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.